These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9890737)

  • 1. Adjuvant therapy and long-term management of differentiated thyroid carcinoma.
    Sherman SI
    Semin Surg Oncol; 1999; 16(1):30-3. PubMed ID: 9890737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrated therapeutic strategies for anaplastic thyroid carcinoma.
    Buzzoni R; Catena L; Cortinovis D; Dognini G; Bajetta E
    Tumori; 2003; 89(5):544-6. PubMed ID: 14870782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiated thyroid carcinoma.
    Hershman JM; Gordon HE
    Curr Ther Endocrinol Metab; 1997; 6():122-6. PubMed ID: 9174719
    [No Abstract]   [Full Text] [Related]  

  • 5. [The basis for radioiodine therapy in differentiated thyroid cancer].
    Haldemann AR
    Ther Umsch; 1999 Jul; 56(7):403-7. PubMed ID: 10434780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the management of differentiated thyroid carcinomas of vesicular origin.
    Borson-Chazot F; Bardet S; Bournaud C; Conte-Devolx B; Corone C; D'Herbomez M; Henry JF; Leenhardt L; Peix JL; Schlumberger M; Wemeau JL; ; Baudin E; Berger N; Bernard MH; Calzada-Nocaudie M; Caron P; Catargi B; Chabrier G; Charrie A; Franc B; Hartl D; Helal B; Kerlan V; Kraimps JL; Leboulleux S; Le Clech G; Menegaux F; Orgiazzi J; Perié S; Raingeard I; Rodien P; Rohmer V; Sadoul JL; Schwartz C; Tenenbaum F; Toubert ME; Tramalloni J; Travagli JP; Vaudrey C
    Ann Endocrinol (Paris); 2008 Dec; 69(6):472-86. PubMed ID: 19137632
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome after high-dose radioiodine therapy for advanced differentiated thyroid carcinoma in childhood.
    Gao YC; Lu HK
    Endocr Res; 2009; 34(4):121-9. PubMed ID: 19878072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
    Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
    Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of patients with differentiated thyroid carcinoma].
    van Tol KM; Jager PL; de Vries EG; Plukker JT; Links TP
    Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1156-7; author reply 1157. PubMed ID: 12092311
    [No Abstract]   [Full Text] [Related]  

  • 10. Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis.
    Cheng W; Ma C; Fu H; Li J; Chen S; Wu S; Wang H
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1353-60. PubMed ID: 23436920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications for adjuvant therapy of thyroid cancer with radioiodine therapy].
    Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():254-65. PubMed ID: 12182034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid carcinoma in children and adolescents: clinical course and therapeutic approach.
    Pazaitou-Panayiotou K
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():508-12. PubMed ID: 16444184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.
    Ben Ghachem T; Yeddes I; Meddeb I; Bahloul A; Mhiri A; Slim I; Ben Slimene MF
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):655-660. PubMed ID: 27225282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years.
    Brignardello E; Gallo M; Baldi I; Palestini N; Piovesan A; Grossi E; Ciccone G; Boccuzzi G
    Eur J Endocrinol; 2007 Apr; 156(4):425-30. PubMed ID: 17389456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Undifferentiated carcinoma of the thyroid gland].
    Busnardo B; Girelli ME; Nacamulli D; Pelizzo MR; Daniele O; Rigon A
    Chir Ital; 1994; 46(4):37-41. PubMed ID: 7533667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The initial treatment of patients with differentiated thyroid carcinoma; consensus and controversies].
    Smit JW
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):454-7. PubMed ID: 11913107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer.
    Bal CS; Kumar A; Pant GS
    Nucl Med Commun; 2003 Feb; 24(2):203-8. PubMed ID: 12548045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The medullary (C-cell) carcinoma of the thyroid. A therapeutic dilemma].
    Schumann J; Hauk H; Leonhardi B
    Chirurg; 1977 Oct; 48(10):666-70. PubMed ID: 913180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer.
    Yoo JY; Stang MT
    Surg Oncol Clin N Am; 2016 Jan; 25(1):41-59. PubMed ID: 26610773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.